DIA / FDLI The Future of Biosimilars in the US: Legal, Regulatory, Scientific, Regulatory, Clinical and Payer Issues
May 04, 2011 – May 05, 2011Bethesda, Maryland
DIA/FDLI The Future of Biosimilars in the US: Legal, Regulatory, Scientific, Regulatory, Clinical and Payer Issues
Vice President, Vaccine Strategy & Innovation
Merck & Co., Inc., United States
FTOPRA, Vice President (Technical)
PAREXEL Consulting, United Kingdom
Alberto Grignolo, PhD
Corporate Vice President, Global Strategy and Services
PAREXEL Consulting, United States
Patricia Knight
President
Knight Capital Consultants, United States
Janet S. Wyatt
Pediatric Nursing Certification Board, United States
Please click on the event web site below for complete information and to register for the conference.
We look forward to seeing you at this ground-breaking conference!
For more information on PAREXEL's Biosimilars development and commercialization expertise, click here.
PAREXEL Speakers Bureau
PAREXEL is your reliable source for knowledgeable speakers on issues affecting the pharmaceutical, biological, and medical device industries.
In addition to being leading subject matter experts, members of the PAREXEL team are experienced at delivering lively and compelling presentations to a broad range of audiences. If you need a speaker for an upcoming event, please click here.
